Yield10 Bioscience, Inc. financial data

Symbol
YTEN on OTC
Industry
Agricultural Production-Crops
Location
19 Presidential Way, Suite 201, Woburn, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Former names
METABOLIX, INC. (to 1/6/2017), METABOLIX INC (to 7/14/2006)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 35.6 % -84.1%
Debt-to-equity -247 % -292%
Return On Equity 436 %
Return On Assets -296 % -58.7%
Operating Margin -1.68K % +69.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 657K shares -89.3%
Common Stock, Shares, Outstanding 642K shares -89.5%
Entity Public Float 9.84M USD +11%
Common Stock, Value, Issued 6K USD -90.2%
Weighted Average Number of Shares Outstanding, Basic 642K shares +169%
Weighted Average Number of Shares Outstanding, Diluted 642K shares +169%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 750K USD +191%
Costs and Expenses 13.3M USD -7.46%
Operating Income (Loss) -12.6M USD +11.1%
Nonoperating Income (Expense) -109K USD -348%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -14.5M USD -7.79%
Income Tax Expense (Benefit) 0 USD -100%
Net Income (Loss) Attributable to Parent -12.7M USD +10.9%
Earnings Per Share, Basic 22 USD/shares +67.3%
Earnings Per Share, Diluted 22 USD/shares +67.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 733K USD -68.6%
Cash, Cash Equivalents, and Short-term Investments 1.07M USD -75.4%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Assets, Current 1.2M USD -60.2%
Property, Plant and Equipment, Net 432K USD -34.8%
Operating Lease, Right-of-Use Asset 1.3M USD -29.9%
Other Assets, Noncurrent 23K USD -65.7%
Assets 2.97M USD -49.4%
Accounts Payable, Current 2.37M USD +407%
Employee-related Liabilities, Current 647K USD +134%
Accrued Liabilities, Current 1.83M USD +32.9%
Liabilities, Current 7.67M USD +210%
Operating Lease, Liability, Noncurrent 1.09M USD -41%
Other Liabilities, Noncurrent 5K USD -58.3%
Liabilities 9.21M USD +74.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -262K USD -7.38%
Retained Earnings (Accumulated Deficit) -420M USD -3.12%
Stockholders' Equity Attributable to Parent -6.24M USD -1163%
Liabilities and Equity 2.97M USD -49.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -903K USD +66.1%
Net Cash Provided by (Used in) Financing Activities 1.21M USD +759%
Net Cash Provided by (Used in) Investing Activities 0 USD -100%
Common Stock, Shares Authorized 150M shares +150%
Common Stock, Shares, Issued 642K shares -89.5%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -547K USD +82.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 745K USD -71.3%
Deferred Tax Assets, Valuation Allowance 14.5M USD +35.4%
Deferred Tax Assets, Gross 15M USD +32.1%
Operating Lease, Liability 2.19M USD -17.2%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -12.7M USD +10.9%
Lessee, Operating Lease, Liability, to be Paid 2.88M USD -20.3%
Property, Plant and Equipment, Gross 2.05M USD +1.64%
Operating Lease, Liability, Current 676K USD +7.64%
Lessee, Operating Lease, Liability, to be Paid, Year Two 833K USD +8.04%
Lessee, Operating Lease, Liability, to be Paid, Year One 810K USD +8.14%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD -100%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 264K USD -35.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 786K USD -0.88%
Deferred Tax Assets, Operating Loss Carryforwards 9.78M USD +40.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 25K USD -96.7%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 66K USD -4.35%
Deferred Tax Assets, Net of Valuation Allowance 480K USD -23.8%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%